Core Viewpoint - The company, Meihao Medical, announced adjustments to its fundraising projects to optimize its global strategic layout and enhance overseas market delivery capabilities [1] Group 1: Fundraising Projects - Meihao Medical plans to reallocate part of the equipment purchased with raised funds for its overseas medical device production and sales platform project [1] - As of June 30, 2025, the two projects have utilized raised funds of 615.30 million yuan and 231.05 million yuan, accounting for 98.05% and 102.78% of the adjusted total investment respectively [1] - The expected transaction amount for the equipment adjustment is no more than 5 million yuan, with the purchasing entity being Miman (Malaysia) Ltd. using its own funds [1] Group 2: Strategic Reasons - The changes are primarily driven by the need to meet the demands of overseas strategic customers and improve the efficiency and return on investment of the raised funds [1] - The adjustments are based on current market changes and operational development needs [1]